CD8A and cancer: developed a hybrid protein oxygen nanocarrier with chlorine e6 (Ce6) for oxygen self-sufficient PDT, which substantially decreased tumor hypoxia and improved the efficacy of PDT and the infiltration of CD8+ T cells at the cancer location (40).